We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

3 hedge funds and large institutions have $1 invested in Ampio Pharmaceuticals Inc. in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding

Funds holding: 2 → 3 (+1)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CCMW
1
Cypress Capital Management (Wyoming)
Wyoming
$1 – -10 -2%

AMPE Hedge Fund Activity: Q2 2025 in Review

3 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2025, worth a combined $1.

Buyers outnumbered sellers: 1 fund opened new AMPE positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

  • 3 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2025, up from 2 in Q1 2025.
  • Funds reported $1 of Ampio Pharmaceuticals Inc. stock for Q2 2025.
  • 1 fund opened new Ampio Pharmaceuticals Inc. positions in Q2 2025 and 0 closed out, a net change of +1 holder.

Based on aggregated 13F filings for Q2 2025.